- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
When taking Suimeikai, special attention should be paid to HLA-B * 5701 gene testing, liver toxicity risk, and drug interactions. The drug cont...
Triumeq is a three in one compound single tablet formulation used for the treatment of HIV-1 infection, containing three active ingredients: ce...
Nausea, stomatitis, and fatigue commonly seen during Alpelisib treatment can be effectively controlled through graded management, medication in...
There are clear restrictions on the use of Alpelisib in patients with severe liver and kidney dysfunction and type 1 diabetes, and the drug reg...
Alpelisib, as a PI3K alpha inhibitor, requires special attention to the management of adverse reactions such as hyperglycemia, rash, and diarrh...
Alpelisib is an oral PI3K α inhibitor, which is mainly used to treat HR+/HER2 advanced or metastatic breast cancer with PIK3CA mutation. This d...
Attention should be paid to the administration method, dosage adjustment, and discontinuation criteria when taking lorlatinib. Specific guideli...
During the treatment of lorlatinib, special attention should be paid to side effects such as edema, peripheral neuropathy, and cognitive impair...
During the treatment of lorlatinib, special attention should be paid to adverse reactions such as central nervous system side effects, hyperlip...
Lorviqua is a third-generation ALK inhibitor used for the treatment of ALK positive non-small cell lung cancer, with the advantage of penetrati...
